Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Lava Therapeutics B.V (NASDAQ: LVTX)

 
LVTX Technical Analysis
5
As on 16th Sep 2025 LVTX SHARE Price closed @ 1.51 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.91 & Strong Sell for SHORT-TERM with Stoploss of 2.93 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

LVTXSHARE Price

Open 1.53 Change Price %
High 1.56 1 Day -0.03 -1.95
Low 1.50 1 Week -0.06 -3.82
Close 1.51 1 Month 0.04 2.72
Volume 637632 1 Year -1.56 -50.81
52 Week High 4.03 | 52 Week Low 0.91
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
ADAP 0.08 14.29%
WBA 11.98 0.50%
OPEN 8.92 -6.01%
CODX 0.64 82.86%
BITF 2.89 16.53%
NVDA 174.88 -1.61%
LMDX 0.02 0.00%
APVO 1.50 4.17%
MARA 17.53 7.94%
 
NASDAQ USA Top Gainers Stocks
MRIN 3450.00 383233.34%
MRIN 3450.00 383233.34%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
HCVIU 9.00 159.37%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
OTRK 0.07 -78.79%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
AXDX 0.03 -66.67%
HPKEW 0.05 -64.29%
TFFP 0.06 -62.50%
MILEW 0.06 -53.85%
 
 
LVTX
Daily Charts		 LVTX
Intraday Charts		 Whats New @
Bazaartrend		 LVTX
Free Analysis
 
LVTX Important Levels Intraday
RESISTANCE1.63
RESISTANCE1.59
RESISTANCE1.57
RESISTANCE1.54
SUPPORT1.48
SUPPORT1.45
SUPPORT1.43
SUPPORT1.39
 
LVTX Forecast September 2025
Share
4th UP Forecast3.53
3rd UP Forecast2.88
2nd UP Forecast2.48
1st UP Forecast2.08
1st DOWN Forecast0.94
2nd DOWN Forecast0.54
3rd DOWN Forecast0.14
4th DOWN Forecast-0.51
 
LVTX Weekly Forecast
4th UP Forecast4.03
3rd UP Forecast3.22
2nd UP Forecast2.72
1st UP Forecast2.22
1st DOWN Forecast0.80
2nd DOWN Forecast0.30
3rd DOWN Forecast-0.20
4th DOWN Forecast-1.01
 
LVTX Forecast2025
4th UP Forecast7.98
3rd UP Forecast5.91
2nd UP Forecast4.62
1st UP Forecast3.34
1st DOWN Forecast-0.32
2nd DOWN Forecast-1.6
3rd DOWN Forecast-2.89
4th DOWN Forecast-4.96
 
 
LVTX Other Details
Segment EQ
Market Capital 191898608.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
LVTX Address
LVTX
 
LVTX Latest News
 
Your Comments and Response on Lava Therapeutics B.V
 
LVTX Business Profile
Lava Therapeutics B.V., a biotechnology company, engages in developing a portfolio of bispecific gamma-delta T cell engagers (gamma-delta bsTCEs) for the treatment of solid tumors and hematologic malignancies based on its platform. Its lead product candidate, LAVA-051, is advancing toward a Phase 1/2a clinical trial for the treatment of CD1d-expressing hematologic cancers, including chronic lymphocytic leukemia, multiple myeloma, and acute myeloid leukemia. The company also develops its gamma-delta bsTCEs in solid tumors, which targets prostate-specific membrane antigen for the treatment of prostate cancer. Lava Therapeutics B.V. has a research collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of potential product candidates. The company was incorporated in 2016 and is headquartered in Utrecht, the Netherlands. Address: Yalelaan 60, Utrecht, Netherlands, 3584 CM
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service